Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001877348 | SCV002135467 | pathogenic | Cortical dysplasia-focal epilepsy syndrome | 2024-11-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gly228*) in the CNTNAP2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNTNAP2 are known to be pathogenic (PMID: 19896112, 21827697, 25045150, 26843181, 27439707). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CNTNAP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1370808). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV004770244 | SCV005378869 | likely pathogenic | not provided | 2023-12-12 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV005040449 | SCV005667270 | likely pathogenic | Autism, susceptibility to, 15; Cortical dysplasia-focal epilepsy syndrome | 2024-03-26 | criteria provided, single submitter | clinical testing |